CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 20,000 shares at $9.45 ($189,000)
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Executive or director change · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale See Remarks sold 3,385 shares at $9.87 ($33,397)
- 4 Planned sale Chief Financial Officer sold 6,494 shares at $10.02 ($65,070)
- 4 Planned sale See Remarks sold 15,787 shares at $9.87 ($155,756)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 4 Planned sale See Remarks sold 6,251 shares at $12.40 ($77,512)
- 4 Planned sale See Remarks sold 27,904 shares at $13.26 ($369,868)
- 4 Planned sale Chief Financial Officer sold 8,996 shares at $13.26 ($119,243)
- 4 Planned sale Chief Marketing Officer sold 4,536 shares at $13.26 ($60,125)
Page 4 of 28 · 558 filings